There will be another excuse if they can't be cash flow positive by Q4 2019 - can you guys still believe after failure in their forecasts. If it is not the weather, its holidays now or something.
All the war and peace, show me the money! Quarterly revenues were down 36% quarter-on-quarter and annualised revenues just $2.28m bulk of which consulting fees , not even the $3m I had in my earlier post.
To be cash flow positive, they probably need to do a big round of redundancy and reduce management compensation - staff cost is fixed cost and it is almost 4x current sales run rate. That's not going to happen if you see their Share Based Expenses in my earlier post being 25-44% of Losses (they contributed 25% of the loss) and latest Appendix 3B showed more performance shares issued at nil consideration. Good companies that look after shareholder interest don't do that- take Appen (APX) as example, for all their great work, share based expenses was just 4.9% of profits in 2018.
BUD Price at posting:
9.5¢ Sentiment: Sell Disclosure: Not Held